All posts by GTCbio


Development of Novel Technologies for Cell and Gene Therapy

GTCbio | July 26th, 2017

Gene therapy is the use of genetic material (usually DNA) to manipulate a patient’s cells as a means to treat diseases, whereas cell therapy is the infusion or transplantation of whole cells into a patient for the treatment of an inherited or acquired disease, both are overlapping fields of biomedical research. In 1990, the first…read more

Advances in Parkinson’s Disease Research and Therapeutics

GTCbio | July 20th, 2017

Parkinson’s disease, the second-most common neurodegenerative disorder affecting 2–3% of the population ≥65 years of age has seen significant developments in past few years in terms of diagnosis and therapeutics. The collaboration between the European Human Brain Project and the U.S. Brain Initiative may result in a milestone for brain related diseases just as the…read more

Prominent Scientists will discuss Evolution of Cell and Gene Therapy

GTCbio | July 11th, 2017

Cell and gene therapy are overlapping fields of biomedical research that address the repair of the direct cause of genetic diseases in the cellular population or DNA, respectively. Cell therapy can be defined as a therapy in which cells or cellular material are injected into a patient. The origins of cell therapy can perhaps be traced to…read more

Past, Present and Future of Neurodegenerative Diseases

GTCbio | July 6th, 2017

Neurodegenerative diseases encompass a broad array of conditions that involve progressive functional loss and neuronal cell death. In 1960s, neuroanatomists started examining neurons, glia, myelin, and synapse structure at the light and electron microscopic levels. At that time, neurology was known as a specialty in which one could diagnose, but not treat. In early 1970s,…read more